Company news
Easton Pharmaceuticals Inc news in 2017
Easton Pharmaceuticals Inc's news releases, calls and decks from 2017, newest first.
Easton Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico; Delivery Date for Purchase Order From Windsor Pharmaceuticals for Central America
December 6, 2017
Easton Pharmaceuticals / Alliance Group Awaits Equipment Delivery, Days Away From Commencing Operations On Its Aggregate Contract After Closing $1.3 Million JV Agreement For 50% Property Ownership Interest and Various Businesses
November 28, 2017
Easton Pharmaceuticals Announces Final Payment Completing $1.3 Million JV Agreement With Alliance Group For a 50% Property Ownership Interest and Various Businesses Including The Cultivation of Medical / Recreational Marijuana For National Canadian Market
October 20, 2017
Easton Pharmaceuticals & JV Partner Alliance Group Announces It Has Cleared Final Hurdles Toward Allowing For The Cultivation of Medical / Recreational Marijuana For National Canadian Market
October 10, 2017
Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean
September 12, 2017
Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract
September 5, 2017
Easton Pharmaceuticals and Alliance Group Announces the Closing Of Its First Aggregate Contract Valued At $6,000,000 CDN On Its 90 Acre Portion Of Industrial Zoned Land
August 23, 2017
Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses
August 16, 2017
Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)
August 10, 2017
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment
July 24, 2017
Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman's Diagnostic And Treatment Products Business For The Mexico Market
June 26, 2017
Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market
June 12, 2017
Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham's UK Vaper Expo
May 24, 2017
Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And a Recurring Royalty
May 15, 2017
Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing, Israel Based Therapeutics Company, Herbs Of Kedem
May 2, 2017
Easton Pharmaceuticals Announces Signing NDA and Starts Negotiations For Acquisition
April 24, 2017
Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.
April 20, 2017
Easton Pharmaceuticals Announces Finalization Of Agreement For The Acquisition Of Major Vaporizer and e-Liquids Manufacturer iBliss Inc; Annual Sales Projected To Once Again Reach $15,000,000 With Healthy Profit Margins in Excess of 40%
April 11, 2017
Easton Pharmaceuticals Announces Advancing $300,000 Payment To CommonSense Ltd. Paving The Way For The Anticipated Closing Of Exclusive Sub-Distribution Agreement For Product AL-Sense with 2nd Quarter Launch
March 22, 2017
Easton Pharmaceuticals Provides Update On Its Previous Investment Into AMFIL Technologies and Their Recent Revenue Producing Acquisitions & The GROzone Technology For The Medical Marijuana Industry; Initiates Negotiations For Proposed Investment
March 15, 2017
Easton Pharmaceuticals Provides Update On Acquiring Major Vaporizer and e-Liquids Manufacturer iBliss, Inc.
March 8, 2017
Easton Pharmaceuticals Announces The Closing Of A Financing Facility With Additional Financing Commitments; Provides Other Updates
March 3, 2017
Easton Pharmaceuticals / BMV Medica Announces Successful Product Sales Launch Conference Of Product Gynofit and Additional Distribution of Product AL-Sense (AmnioSense) With Multi-National Pharmaceutical Company Gedeon Richter
February 21, 2017
Easton Pharmaceuticals Provides Update On its Licensed Women's Diagnostics Products (VS-Sense, AL-Sense) and Other Updates
February 8, 2017
Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been Received For February 16th Product Launch in Puerto Vallarta, Mexico
February 3, 2017
Easton Pharmaceuticals Signs Letter Of Intent to Acquire Major Vaporizer and e-Liquids Manufacturer iBliss Inc.
January 23, 2017
Easton Pharmaceuticals and Partner BMV Medica Announce Receipt of First Purchase Order For Mexico's Launch for Gynofit -- Lactic Acid Gel Treatment From Gedeon Richter
January 4, 2017